Samsung Bioepis Renews Bid To Invalidate Regeneron Eye Drug Patent on March 22, 2025 eye patent Regeneron Pharmaceuticals Samsung Bioepis + VEGF eye patent Regeneron Pharmaceuticals Samsung Bioepis VEGF
Samsung Bioepis Fails to Invalidate Regeneron Patents in S. Korea on December 01, 2024 patent patentrip Regeneron Samsung Bioepis + VEGF patent patentrip Regeneron Samsung Bioepis VEGF